1.Uterine fibroids. 2. Adenomyosis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Diagnosed with uterine fibroids or adenomyosis/adenomyoma via clinical examination, laboratory tests, and imaging (ultrasound ± MRI). 2.Presence of disease-related clinical symptoms with a willingness to undergo treatment; 3.Assessed by the obstetrics and gynaecology/interventional ultrasound team as suitable for ultrasound-guided MWA or RFA treatment. 4.Able to understand the study content and sign the informed consent form, and willing to attend follow-up appointments in accordance with the follow-up plan. 5. Age: Women aged 18–55.
Exclusion criteria
Exclusion criteria: 1.Suspected or confirmed gynaecological malignancy (e.g. uterine sarcoma, endometrial cancer, cervical cancer, etc.) or high-grade cervical lesion. 2.Pregnancy or breastfeeding. 3.Severe coagulation disorder or recent use of anticoagulant/antiplatelet therapy that cannot be discontinued; or active bleeding. 4.Combined severe organ dysfunction (heart, lung, liver, kidney, etc.) or inability to tolerate sedation, analgesia, or anaesthesia. 5.Patients with uncontrolled acute pelvic inflammatory disease. 6.Inability to complete imaging follow-up or expected poor compliance. 7.Other circumstances deemed by the investigator to be unsuitable for enrolment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion and uterine volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of AE/SAE; | — |
Countries
China
Contacts
Beijing Friendship Hospital ,Capital Medical University